 | | QVO | | 表記: | 2-[4-(3-chlorophenyl)-2,5-bis(oxidanylidene)pyrrolo[3,4-b]pyridin-1-yl]-~{N}-[4-(1~{H}-1,2,3,4-tetrazol-5-yl)phenyl]ethanamide | | 組成式: | C22 H14 Cl N7 O3 | | SMILES: | Clc1cccc(c1)C2=CC(=O)N(CC(=O)Nc3ccc(cc3)c4[nH]nnn4)C5=C2C(=O)N=C5 | | InChi: | InChI=1S/C22H14ClN7O3/c23-14-3-1-2-13(8-14)16-9-19(32)30(17-10-24-22(33)20(16)17)11-18(31)25-15-6-4-12(5-7-15)21-26-28-29-27-21/h1-10H,11H2,(H,25,31)(H,26,27,28,29) | | 定義日: | 2022-11-15 | | 最終更新日: | 2023-09-08 | | 公開日: | 2023-09-13 | | 識別子（ID）: | 2-[4-(3-chlorophenyl)-2,5-bis(oxidanylidene)pyrrolo[3,4-b]pyridin-1-yl]-~{N}-[4-(1~{H}-1,2,3,4-tetrazol-5-yl)phenyl]ethanamide |
|
 | | UZF | | 表記: | 1-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-sulfanyl-ethanone | | 組成式: | C16 H15 N O S | | SMILES: | SCC(=O)N1c2ccccc2CCc3ccccc13 | | InChi: | InChI=1S/C16H15NOS/c18-16(11-19)17-14-7-3-1-5-12(14)9-10-13-6-2-4-8-15(13)17/h1-8,19H,9-11H2 | | 定義日: | 2023-06-30 | | 最終更新日: | 2023-08-25 | | 公開日: | 2023-08-30 | | 識別子（ID）: | 1-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-sulfanyl-ethanone |
|
 | | WIV | | 表記: | 6-cyclopropyl-~{N}-(2-methylindazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide | | 組成式: | C21 H22 N6 O | | SMILES: | CC(C)n1ncc2c1nc(cc2C(=O)Nc3ccc4nn(C)cc4c3)C5CC5 | | InChi: | InChI=1S/C21H22N6O/c1-12(2)27-20-17(10-22-27)16(9-19(24-20)13-4-5-13)21(28)23-15-6-7-18-14(8-15)11-26(3)25-18/h6-13H,4-5H2,1-3H3,(H,23,28) | | 定義日: | 2023-05-15 | | 最終更新日: | 2023-08-25 | | 公開日: | 2023-08-30 | | 識別子（ID）: | 6-cyclopropyl-~{N}-(2-methylindazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide |
|
 | | WJL | | 表記: | 6-cyclopropyl-~{N}-(1~{H}-indazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide | | 組成式: | C20 H20 N6 O | | SMILES: | CC(C)n1ncc2c1nc(cc2C(=O)Nc3ccc4[nH]ncc4c3)C5CC5 | | InChi: | InChI=1S/C20H20N6O/c1-11(2)26-19-16(10-22-26)15(8-18(24-19)12-3-4-12)20(27)23-14-5-6-17-13(7-14)9-21-25-17/h5-12H,3-4H2,1-2H3,(H,21,25)(H,23,27) | | 定義日: | 2023-05-16 | | 最終更新日: | 2023-08-25 | | 公開日: | 2023-08-30 | | 識別子（ID）: | 6-cyclopropyl-~{N}-(1~{H}-indazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide |
|
 | | I8E | | 表記: | Tetrahydrocannabivarin | | 組成式: | C19 H26 O2 | | SMILES: | CCCc1cc2OC(C)(C)C3CCC(C)=CC3c2c(O)c1 | | InChi: | InChI=1S/C19H26O2/c1-5-6-13-10-16(20)18-14-9-12(2)7-8-15(14)19(3,4)21-17(18)11-13/h9-11,14-15,20H,5-8H2,1-4H3/t14-,15-/m1/s1 | | 別名: | (6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol | | 定義日: | 2023-05-04 | | 最終更新日: | 2023-08-18 | | 公開日: | 2023-08-23 | | 識別子（ID）: | (6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol |
|
 | | USF | | 表記: | 2-[[8-azanyl-7-fluoranyl-6-(8-methyl-2,3-dihydro-1~{H}-pyrido[2,3-b][1,4]oxazin-7-yl)isoquinolin-3-yl]amino]-6-propan-2-yl-5,8-dihydro-4~{H}-pyrazolo[1,5-d][1,4]diazepin-7-one | | 組成式: | C27 H29 F N8 O2 | | SMILES: | CC(C)N1CCc2cc(Nc3cc4cc(c(F)c(N)c4cn3)c5cnc6OCCNc6c5C)nn2CC1=O | | InChi: | InChI=1S/C27H29FN8O2/c1-14(2)35-6-4-17-10-22(34-36(17)13-23(35)37)33-21-9-16-8-18(24(28)25(29)20(16)12-31-21)19-11-32-27-26(15(19)3)30-5-7-38-27/h8-12,14,30H,4-7,13,29H2,1-3H3,(H,31,33,34) | | 別名: | 2-[8-Amino-7-fluoro-6-(8-methyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-7-yl)-isoquinolin-3-ylamino]-6-isopropyl-5,6-dihydro-4H-1,6,8a-triaza-azulen-7-one | | 定義日: | 2023-02-10 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | 2-[[8-azanyl-7-fluoranyl-6-(8-methyl-2,3-dihydro-1~{H}-pyrido[2,3-b][1,4]oxazin-7-yl)isoquinolin-3-yl]amino]-6-propan-2-yl-5,8-dihydro-4~{H}-pyrazolo[1,5-d][1,4]diazepin-7-one |
|
 | | UWO | | 表記: | methyl (6~{R})-5-ethanoyl-7-oxidanylidene-6-[4-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-6~{H}-benzo[b][1,4]benzodiazepine-2-carboxylate | | 組成式: | C24 H21 F3 N2 O4 | | SMILES: | COC(=O)c1ccc2N([CH](c3ccc(cc3)C(F)(F)F)C4=C(CCCC4=O)Nc2c1)C(C)=O | | InChi: | InChI=1S/C24H21F3N2O4/c1-13(30)29-19-11-8-15(23(32)33-2)12-18(19)28-17-4-3-5-20(31)21(17)22(29)14-6-9-16(10-7-14)24(25,26)27/h6-12,22,28H,3-5H2,1-2H3/t22-/m1/s1 | | 定義日: | 2023-06-23 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | methyl (6~{R})-5-ethanoyl-7-oxidanylidene-6-[4-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-6~{H}-benzo[b][1,4]benzodiazepine-2-carboxylate |
|
 | | ZJ5 | | 表記: | ~{N}-[[(3~{R})-1,1-bis(oxidanyl)-3~{H}-2,1$l^{4}-benzoxaborol-3-yl]methyl]methanesulfonamide | | 組成式: | C9 H13 B N O5 S | | SMILES: | C[S](=O)(=O)NC[CH]1O[B](O)(O)c2ccccc12 | | InChi: | InChI=1S/C9H13BNO5S/c1-17(14,15)11-6-9-7-4-2-3-5-8(7)10(12,13)16-9/h2-5,9,11-13H,6H2,1H3/t9-/m0/s1 | | 定義日: | 2023-06-26 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | ~{N}-[[(3~{R})-1,1-bis(oxidanyl)-3~{H}-2,1$l^{4}-benzoxaborol-3-yl]methyl]methanesulfonamide |
|
 | | YHG | | 表記: | (3~{S})-~{N}-[4-[[5-(1,6-dimethylpyrazolo[3,4-b]pyridin-4-yl)-3-methyl-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-1-yl]methyl]-1-bicyclo[2.2.2]octanyl]morpholine-3-carboxamide | | 組成式: | C29 H40 N8 O2 | | SMILES: | Cn1ncc2c(cc(C)nc12)N3CCc4n(CC56CCC(CC5)(CC6)NC(=O)[CH]7COCCN7)nc(C)c4C3 | | InChi: | InChI=1S/C29H40N8O2/c1-19-14-25(21-15-31-35(3)26(21)32-19)36-12-4-24-22(16-36)20(2)34-37(24)18-28-5-8-29(9-6-28,10-7-28)33-27(38)23-17-39-13-11-30-23/h14-15,23,30H,4-13,16-18H2,1-3H3,(H,33,38)/t23-,28-,29+/m0/s1 | | 定義日: | 2023-06-16 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | (3~{S})-~{N}-[4-[[5-(1,6-dimethylpyrazolo[3,4-b]pyridin-4-yl)-3-methyl-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-1-yl]methyl]-1-bicyclo[2.2.2]octanyl]morpholine-3-carboxamide |
|
 | | K06 | | 表記: | 6-[4-(1-azanyl-3-methyl-3-oxidanyl-cyclobutyl)phenyl]-7-phenyl-1-propyl-pyrido[2,3-b][1,4]oxazin-2-one | | 組成式: | C27 H29 N3 O3 | | SMILES: | CCCN1C(=O)COc2nc(c3ccc(cc3)[C]4(N)C[C](C)(O)C4)c(cc12)c5ccccc5 | | InChi: | InChI=1S/C27H29N3O3/c1-3-13-30-22-14-21(18-7-5-4-6-8-18)24(29-25(22)33-15-23(30)31)19-9-11-20(12-10-19)27(28)16-26(2,32)17-27/h4-12,14,32H,3,13,15-17,28H2,1-2H3/t26-,27- | | 定義日: | 2023-08-10 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | 6-[4-(1-azanyl-3-methyl-3-oxidanyl-cyclobutyl)phenyl]-7-phenyl-1-propyl-pyrido[2,3-b][1,4]oxazin-2-one |
|
 | | LS9 | | 表記: | pyridin-3-ylboronic acid | | 組成式: | C5 H6 B N O2 | | SMILES: | OB(O)c1cccnc1 | | InChi: | InChI=1S/C5H6BNO2/c8-6(9)5-2-1-3-7-4-5/h1-4,8-9H | | 定義日: | 2022-07-11 | | 最終更新日: | 2023-08-11 | | 公開日: | 2023-08-16 | | 識別子（ID）: | pyridin-3-ylboronic acid |
|
 | | IGS | | 表記: | ~{N}-[3-[[5-[1-[2,6-bis(fluoranyl)-3-[(3-phenylphenyl)sulfonylamino]phenyl]-1,2,3-triazol-4-yl]-1~{H}-pyrazolo[3,4-b]pyridin-3-yl]oxy]propyl]propanamide | | 組成式: | C32 H28 F2 N8 O4 S | | SMILES: | CCC(=O)NCCCOc1n[nH]c2ncc(cc12)c3cn(nn3)c4c(F)ccc(N[S](=O)(=O)c5cccc(c5)c6ccccc6)c4F | | InChi: | InChI=1S/C32H28F2N8O4S/c1-2-28(43)35-14-7-15-46-32-24-17-22(18-36-31(24)38-39-32)27-19-42(41-37-27)30-25(33)12-13-26(29(30)34)40-47(44,45)23-11-6-10-21(16-23)20-8-4-3-5-9-20/h3-6,8-13,16-19,40H,2,7,14-15H2,1H3,(H,35,43)(H,36,38,39) | | 定義日: | 2022-06-30 | | 最終更新日: | 2023-08-04 | | 公開日: | 2023-08-09 | | 識別子（ID）: | ~{N}-[3-[[5-[1-[2,6-bis(fluoranyl)-3-[(3-phenylphenyl)sulfonylamino]phenyl]-1,2,3-triazol-4-yl]-1~{H}-pyrazolo[3,4-b]pyridin-3-yl]oxy]propyl]propanamide |
|
 | | IGV | | 表記: | ~{N}-[2,4-bis(fluoranyl)-3-[4-[3-[(3~{S})-1-propanoylpyrrolidin-3-yl]oxy-1~{H}-pyrazolo[3,4-b]pyridin-5-yl]-1,2,3-triazol-1-yl]phenyl]-3-phenyl-benzenesulfonamide | | 組成式: | C33 H28 F2 N8 O4 S | | SMILES: | CCC(=O)N1CC[CH](C1)Oc2n[nH]c3ncc(cc23)c4cn(nn4)c5c(F)ccc(N[S](=O)(=O)c6cccc(c6)c7ccccc7)c5F | | InChi: | InChI=1S/C33H28F2N8O4S/c1-2-29(44)42-14-13-23(18-42)47-33-25-16-22(17-36-32(25)38-39-33)28-19-43(41-37-28)31-26(34)11-12-27(30(31)35)40-48(45,46)24-10-6-9-21(15-24)20-7-4-3-5-8-20/h3-12,15-17,19,23,40H,2,13-14,18H2,1H3,(H,36,38,39)/t23-/m0/s1 | | 定義日: | 2022-06-30 | | 最終更新日: | 2023-08-04 | | 公開日: | 2023-08-09 | | 識別子（ID）: | ~{N}-[2,4-bis(fluoranyl)-3-[4-[3-[(3~{S})-1-propanoylpyrrolidin-3-yl]oxy-1~{H}-pyrazolo[3,4-b]pyridin-5-yl]-1,2,3-triazol-1-yl]phenyl]-3-phenyl-benzenesulfonamide |
|
 | | ZVB | | 表記: | 2-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridine | | 組成式: | C10 H12 N2 | | SMILES: | CC(C)c1cc2ncccc2[NH]1 | | InChi: | InChI=1S/C10H12N2/c1-7(2)9-6-10-8(12-9)4-3-5-11-10/h3-7,12H,1-2H3 | | 定義日: | 2023-07-05 | | 最終更新日: | 2023-07-21 | | 公開日: | 2023-07-26 | | 識別子（ID）: | 2-(propan-2-yl)-1H-pyrrolo[3,2-b]pyridine |
|
 | | WX8 | | 表記: | 3-[(2E)-4-{5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)-1H-benzimidazol-1-yl}but-2-en-1-yl]-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-3H-imidazo[4,5-b]pyridine-6-carboxamide | | 組成式: | C36 H39 N11 O8 | | SMILES: | CCc1nc(C)oc1C(=O)Nc1nc2cc(cnc2n1CC=CCn1c2c(OCCCO)cc(cc2nc1NC(=O)c1oc(C)nc1CC)C(N)=O)C(N)=O | | InChi: | InChI=1S/C36H39N11O8/c1-5-22-28(54-18(3)40-22)33(51)44-35-42-24-14-20(30(37)49)16-26(53-13-9-12-48)27(24)46(35)10-7-8-11-47-32-25(15-21(17-39-32)31(38)50)43-36(47)45-34(52)29-23(6-2)41-19(4)55-29/h7-8,14-17,48H,5-6,9-13H2,1-4H3,(H2,37,49)(H2,38,50)(H,42,44,51)(H,43,45,52)/b8-7+ | | 定義日: | 2023-05-21 | | 最終更新日: | 2023-07-21 | | 公開日: | 2023-07-26 | | 識別子（ID）: | 3-[(2E)-4-{5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)-1H-benzimidazol-1-yl}but-2-en-1-yl]-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-3H-imidazo[4,5-b]pyridine-6-carboxamide |
|
 | | ZTV | | 表記: | (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1H-imidazo[4,5-b]pyridine | | 組成式: | C21 H26 N6 O2 | | SMILES: | CC1COCCN1c1cc(nc2nc([NH]c21)c1ccccn1)N1CCOCC1C | | InChi: | InChI=1S/C21H26N6O2/c1-14-12-28-9-7-26(14)17-11-18(27-8-10-29-13-15(27)2)23-21-19(17)24-20(25-21)16-5-3-4-6-22-16/h3-6,11,14-15H,7-10,12-13H2,1-2H3,(H,23,24,25)/t14-,15+/m1/s1 | | 定義日: | 2023-04-03 | | 最終更新日: | 2023-07-14 | | 公開日: | 2023-07-19 | | 識別子（ID）: | (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1H-imidazo[4,5-b]pyridine |
|
 | | ZUO | | 表記: | (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine | | 組成式: | C19 H25 N7 O2 | | SMILES: | CC1COCCN1c1cc(nc2[NH]c(nc21)c1cc[NH]n1)N1CCOCC1C | | InChi: | InChI=1S/C19H25N7O2/c1-12-10-27-7-5-25(12)15-9-16(26-6-8-28-11-13(26)2)21-19-17(15)22-18(23-19)14-3-4-20-24-14/h3-4,9,12-13H,5-8,10-11H2,1-2H3,(H,20,24)(H,21,22,23)/t12-,13+/m1/s1 | | 定義日: | 2023-04-04 | | 最終更新日: | 2023-07-14 | | 公開日: | 2023-07-19 | | 識別子（ID）: | (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine |
|
 | | WYH | | 表記: | 2,3,4,9-tetrahydro-1~{H}-pyrido[3,4-b]indole | | 組成式: | C11 H12 N2 | | SMILES: | C1Cc2c(CN1)[nH]c3ccccc23 | | InChi: | InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2 | | 定義日: | 2022-07-05 | | 最終更新日: | 2023-07-07 | | 公開日: | 2023-07-12 | | 識別子（ID）: | 2,3,4,9-tetrahydro-1~{H}-pyrido[3,4-b]indole |
|
 | | YWX | | 表記: | 2-{3-[(Z)-iminomethyl]-1H-1,2,4-triazol-1-yl}-1-{(3M)-3-[2-(trifluoromethyl)phenyl]-6H-pyrrolo[3,4-b]pyridin-6-yl}ethan-1-one | | 組成式: | C19 H13 F3 N6 O | | SMILES: | O=C(Cn1cnc(C=N)n1)n1cc2cc(cnc2c1)c1ccccc1C(F)(F)F | | InChi: | InChI=1S/C19H13F3N6O/c20-19(21,22)15-4-2-1-3-14(15)12-5-13-8-27(9-16(13)24-7-12)18(29)10-28-11-25-17(6-23)26-28/h1-9,11,23H,10H2/b23-6- | | 別名: | inhibitor CT1, bound form | | 定義日: | 2023-03-02 | | 最終更新日: | 2023-07-07 | | 公開日: | 2023-07-12 | | 識別子（ID）: | 2-{3-[(Z)-iminomethyl]-1H-1,2,4-triazol-1-yl}-1-{(3M)-3-[2-(trifluoromethyl)phenyl]-6H-pyrrolo[3,4-b]pyridin-6-yl}ethan-1-one |
|
 | | YXU | | 表記: | 5-methoxy-1H-pyrrolo[3,2-b]pyridine | | 組成式: | C8 H8 N2 O | | SMILES: | COc1ccc2[NH]ccc2n1 | | InChi: | InChI=1S/C8H8N2O/c1-11-8-3-2-6-7(10-8)4-5-9-6/h2-5,9H,1H3 | | 定義日: | 2023-06-22 | | 最終更新日: | 2023-07-07 | | 公開日: | 2023-07-12 | | 識別子（ID）: | 5-methoxy-1H-pyrrolo[3,2-b]pyridine |
|
 | | X3K | | 表記: | N-[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide | | 組成式: | C16 H13 N3 O | | SMILES: | C=CC(=O)Nc1cccc(c1)c2ccnc3[nH]ccc23 | | InChi: | InChI=1S/C16H13N3O/c1-2-15(20)19-12-5-3-4-11(10-12)13-6-8-17-16-14(13)7-9-18-16/h2-10H,1H2,(H,17,18)(H,19,20) | | 別名: | N-(3-(1h-pyrrolo[2,3-B]pyridin-4-yl)phenyl)acrylamide | | 定義日: | 2023-05-31 | | 最終更新日: | 2023-06-30 | | 公開日: | 2023-07-05 | | 識別子（ID）: | ~{N}-[3-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide |
|
 | | YDB | | 表記: | 1-[(2R)-2-{2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetamido}-2-boronoethyl]-1H-1,2,3-triazole-4-carboxylic acid | | 組成式: | C9 H12 B N7 O5 S2 | | SMILES: | O=C(CSc1nnc(N)s1)NC(Cn1cc(nn1)C(=O)O)B(O)O | | InChi: | InChI=1S/C9H12BN7O5S2/c11-8-14-15-9(24-8)23-3-6(18)12-5(10(21)22)2-17-1-4(7(19)20)13-16-17/h1,5,21-22H,2-3H2,(H2,11,14)(H,12,18)(H,19,20)/t5-/m0/s1 | | 定義日: | 2023-01-25 | | 最終更新日: | 2023-06-30 | | 公開日: | 2023-07-05 | | 識別子（ID）: | 1-[(2R)-2-{2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetamido}-2-boronoethyl]-1H-1,2,3-triazole-4-carboxylic acid |
|
 | | XER | | 表記: | 3-chloro-5-fluorothieno[3,2-b]thiophene-2-carboxylic acid | | 組成式: | C7 H2 Cl F O2 S2 | | SMILES: | Fc1cc2sc(c(Cl)c2s1)C(=O)O | | InChi: | InChI=1S/C7H2ClFO2S2/c8-4-5-2(1-3(9)13-5)12-6(4)7(10)11/h1H,(H,10,11) | | 定義日: | 2022-11-14 | | 最終更新日: | 2023-06-30 | | 公開日: | 2023-07-05 | | 識別子（ID）: | 3-chloro-5-fluorothieno[3,2-b]thiophene-2-carboxylic acid |
|
 | | LBJ | | 表記: | 6-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole | | 組成式: | C12 H14 N2 O | | SMILES: | COc1ccc2[nH]c3CNCCc3c2c1 | | InChi: | InChI=1S/C12H14N2O/c1-15-8-2-3-11-10(6-8)9-4-5-13-7-12(9)14-11/h2-3,6,13-14H,4-5,7H2,1H3 | | 定義日: | 2022-06-29 | | 最終更新日: | 2023-06-30 | | 公開日: | 2023-07-05 | | 識別子（ID）: | 6-methoxy-2,3,4,9-tetrahydro-1~{H}-pyrido[3,4-b]indole |
|
 | | F9C | | 表記: | 1-(6-bromanyl-7-methyl-imidazo[4,5-b]pyridin-3-yl)-3-[(2R,3S)-3-oxidanylpiperidin-2-yl]propan-2-one | | 組成式: | C15 H19 Br N4 O2 | | SMILES: | Cc1c(Br)cnc2n(CC(=O)C[CH]3NCCC[CH]3O)cnc12 | | InChi: | InChI=1S/C15H19BrN4O2/c1-9-11(16)6-18-15-14(9)19-8-20(15)7-10(21)5-12-13(22)3-2-4-17-12/h6,8,12-13,17,22H,2-5,7H2,1H3/t12-,13+/m1/s1 | | 定義日: | 2020-04-20 | | 最終更新日: | 2023-06-30 | | 公開日: | 2023-07-05 | | 識別子（ID）: | 1-(6-bromanyl-7-methyl-imidazo[4,5-b]pyridin-3-yl)-3-[(2~{R},3~{S})-3-oxidanylpiperidin-2-yl]propan-2-one |
|
